Rosmarinic acid monotherapy is better than the combination of rosmarinic acid and telmisartan in preventing podocyte detachment and inhibiting the progression of diabetic nephropathy in rats
Nur Samsu,1 Setyawati Soeharto,2 Muhaimin Rifai,3 Achmad Rudijanto41Department of Internal Medicine, Division of Nephrology and Hypertension, Faculty of Medicine; 2Department of Pharmacology, Faculty of Medicine; 3Department of Biology, Faculty of Mathematics and Sciences; 4Department of Internal Me...
Saved in:
Main Authors: | Samsu N, Soeharto S, Rifai M, Rudijanto A |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/dfb10b83fb5e44e79a63eaa11fe96430 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Potential Role of Rosmarinic Acid and Sinensetin as α-Amylase Inhibitor: In Silico Study
by: Hazna Noor Meidinna, et al.
Published: (2019) -
Rosmarinic Acid Delays Tomato Fruit Ripening by Regulating Ripening-Associated Traits
by: Changan Zhu, et al.
Published: (2021) -
Rosmarinic acid ameliorates renal ischemia reperfusion damage in rats
by: Majid Tavafi, et al.
Published: (2020) -
The Beneficial Effect of Rosmarinic Acid on Benzophenone-3-Induced Alterations in Human Skin Fibroblasts
by: Anna Galicka, et al.
Published: (2021) -
Safety profile of solid lipid nanoparticles loaded with rosmarinic acid for oral use: in vitro and animal approaches
by: Madureira AR, et al.
Published: (2016)